Please login to the form below

Not currently logged in
Email:
Password:

Dr Martin Rothman joins Sofinnova Partners

He becomes the firm’s venture partner

RothmanLife Science-focused European venture capital firm, Sofinnova Partners, has appointed Dr Martin Rothman as venture partner.

Rothman brings 40 years of experience along with an international network in the medical field to Sofinnova Partners. There, he will focus on helping the team identify and evaluate “promising” medical device companies.

His new position at the firm will also see him take on a mentor role, as he will guide entrepreneurs and physicians launching clinical innovations.

Rothman said: “I am thrilled to join Sofinnova Partners’ team as venture partner.

“We share a common vision of entrepreneurship and a passion for bringing innovative therapies to patients and the medical community.”

Until recently, Rothman was vice president of medical affairs for coronary, structural heart and renal denervation for Medtronic, where he held that position since 2010.

Commenting on the appointment, Antoine Papiernik, managing partner and chairman of Sofinnova Partners, said: “Martin is an exceptional physician and repeat entrepreneur.

“His experience ideally complements our team and represents a key asset for Sofinnova Partners at a time when our activity is growing.”

22nd May 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Cutting through the noise
AstraZeneca looks to lead an R&D revolution as the company invests in CRISPR and functional genomics drug discovery...
International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...

Infographics